Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ABCL
ABCL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABCL News
11 Stocks That Have Plummeted and Appear to Be Good Investment Opportunities
6d ago
Barron's
Salesforce Shares and 10 Other Stocks That Have Plummeted and Appear to Be Good Investments
6d ago
Barron's
AbCellera Biologics Initiates Phase 2 of pPREMIUM Clinical Trial
Jan 12 2026
Yahoo Finance
AbCellera resolves patent dispute with Bruker regarding microfluidic technology.
Dec 18 2025
SeekingAlpha
AbCellera to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Dec 08 2025
Newsfilter
Insider Buying Update for Monday, December 1: DASH, ABCL
Dec 01 2025
NASDAQ.COM
Biotech Stocks MODD, LAB, HOWL, COGT, LGVN, and ABCL Surge in After-Hours Trading - Nov 26
Nov 28 2025
NASDAQ.COM
Biotech Update: IFRX, ABCL, RLYB Stand Out as Significant Gainers After Hours
Nov 10 2025
NASDAQ.COM
AI Stocks Continue Decline, Nasdaq 100 Set for Worst Week Since April: Market Movers on Friday
Nov 07 2025
Benzinga
AI Stocks Decline Once More, Bitcoin Approaches $100,000: What’s Influencing Markets This Thursday?
Nov 06 2025
Benzinga
AbCellera Biologics Gains Traction as Stock Reaches 52-Week Peak
Oct 02 2025
NASDAQ.COM
ZCMD, ABCL, VOR, IXHL, OVID, BFRG Surge in After-Hours Trading Due to Clinical Progress and Recent Developments
Oct 02 2025
NASDAQ.COM
AbCellera Biologics Inc. (ABCL) Shows Strong Momentum: Is It a Good Investment?
Sep 29 2025
NASDAQ.COM
Notable ABCL Call Options Set for November 21st
Sep 19 2025
NASDAQ.COM
AbCellera Names Dr. Sarah Noonberg as Chief Medical Officer
Sep 10 2025
Newsfilter
AbCellera signals clinical-stage transition with first patient dosing for ABCL635 and targets mid-2026 data milestone
Aug 07 2025
SeekingAlpha
Show More News
